Efficacies of Atropine/2-PAM and Atropine/HI-6 in Treating Monkeys Intoxicated with Organophosphonate Nerve Agents

Abstract

The efficacies of atropine (ATR)/ 2-PAM and ATRl HI-6 in treating male rhesus monkeys injected with the neurotoxic organophosphonate (OP) agents GA, GB, GD, GF, or VX were compared. Experiments were conducted using no more than 8 monkeys per OP and treatment regimen. Doses were selected using a modified up-and-down experimental design, challenging one monkey per day per OP and treatment. Results were used to approximate the median lethal dose (MLD) for groups of treated monkeys or monkeys given only a vehicle following challenge with an OP. Mortality and signs of intoxication with each treatment were statistically compared. Doses of 2-PAM (25.7 mgl kg) or HI-6 (50 mgl kg) and atropine (0.4 mg free base! kg) were given in a single intramuscular (IM) injection 1 min following challenge with an OP. Strong and well-defined relationships between agent dose and 10-h lethality were observed in untreated animals. The 10-h IM OP MLDs for untreated monkeys were estimated to be 80, 43, 8.0, 22, and 7.4 μg/kg for GA, GB, GD, GF, and VX, respectively. No statistical differences w ere found between AT Rl 2-PAM and AT Rl HI-6 treatment efficacies in preventing lethality for any of the OPs. Both oxime combinations appear to provide protection against a 2 × 10-h MLD of GA, GF, or VX; only

Keywords

2-PAM atropine HI-6 monkeys nerve agents organophosphates

References

Feder, P. I. , Hobson, D. W. , Olson, C. T. , Joiner, R. L. , and Matthews, M. C. 1991a. Stagewise, adaptive dose allocation for quantal response dose-response studies. Neurosci. Biobehav. Rev. 15:109–1114.

Feder P. I. , Olson, C. T. , Hobson, D. W. , Matthews, M. C , and Joiner, R. L. 1991b. Stagewise, group sequential experimental designs for quantal responses: one-sample and two-sample comparisons. Neurosci. Biobehav. Rev. 15:129–133.

Feder, P. I. , Olson, C. T. , Hobson, D. W. , Matthews, M. C , and Joiner, R. L. 1991c. Statistical analysis of dose-response experiments by maximum likelihood analysis and iteratively reweighted nonlinear least squares regression techniques. Drug Inform. J. 25:323–334.

Feder, P. I. , Hobson, D. W. , Olson, C. T. , Joiner, R. L. , and Matthews, M. C. 1992a. Statistical design considerations for stagewise, adaptive dose allocation in dose-response studies. In Biopharmaceutical sequential statistical applications, ed. K. E. Peace . New York: Dekker.

Feder, P. I. , Olson, C. T. , Hobson, D. W. , Matthews, M. C , and Joiner, R. L. 1992b. Stagewise, group sequential experimental designs for comparisons of quantal response levels obtained with candidate treatment regimens versus those with a concurrent control or a specified standard. In Biopharmaceutical sequential statistical applications, ed. K. E. Peace . New York: Dekker.

Koplovitz I. , Gresham, V. C , Dochterman, L. W. , Kaminskis, A. , and Stewart, J. R. 1992. Evaluation of the toxicity, pathology, and treatment of cyclo-hexylmethylphosphonofluoridate (CMPF) poisoning in rhesus monkeys. Arch. Toxicol. 66:622–628.

Olson, C. T., Menton, R. G., Kiser, R. C, Matthews, M. C, Hayes, T. L., Singer, A. W., and Dill, G. S. 1991. Battelle Final Report on Task 89-12: Characterization of somantoxicity in atropine and oxime (HI-6 and MMB-4) treated rhesus monkeys. Submitted to U.S. Army Medical Research and Development Command.

Olson, C. T., Menton, R. G., Kiser, R. C, Hayes, T. L., Matthews, M. C, Singer, A. W., and Johnson, J. B. 1995. Battelle Final Report on Task 92-30: Determination of the minimum effective pyridostigmine pretreatment dose in monkeys challenged with 5 X LD50 soman and treated with atropine/2-PAM. Submitted to U.S. Army Medical Research and Materiel Command.